Jupiter Neurosciences, Inc.
JUNS
$0.64
$0.00761.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 118.72% | -9.10% | |||
| Gross Profit | -118.72% | 9.10% | |||
| SG&A Expenses | 213.10% | -11.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 195.52% | -11.42% | |||
| Operating Income | -195.52% | 11.42% | |||
| Income Before Tax | -158.48% | -288.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -158.48% | -288.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -158.48% | -288.76% | |||
| EBIT | -195.52% | 11.42% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -154.21% | -266.67% | |||
| Normalized Basic EPS | -137.82% | 17.93% | |||
| EPS Diluted | -141.50% | -300.00% | |||
| Normalized Diluted EPS | -137.82% | 8.46% | |||
| Average Basic Shares Outstanding | 1.86% | 12.82% | |||
| Average Diluted Shares Outstanding | 1.86% | 1.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||